Gantenerumab does not slow clinical decline in early Alzheimer disease, research finds

by Elana GotkineThe use of gantenerumab leads to lower amyloid plaque burden at 116 weeks, but is not associated with slower clinical decline among patients with early Alzheimer disease, according to

Updated on: February 24,2024

Gantenerumab does not slow clinical decline in early Alzheimer disease, research finds

by Elana GotkineThe use of gantenerumab leads to lower amyloid plaque burden at 116 weeks, but is not associated with slower clinical decline among patients with early Alzheimer disease, according to

Updated on:February 24,2024

MS treatment that 'resets' immune system may halt disease progression for at least five years

by Imperial College LondonDemyelination by MS. The CD68 colored tissue shows several macrophages in the area of the lesion. Original scale 1:100. Credit:CC BY-SA 3.0Marvin 101/Wikiped

Updated on: April 01,2024

MS treatment that 'resets' immune system may halt disease progression for at least five years

by Imperial College LondonDemyelination by MS. The CD68 colored tissue shows several macrophages in the area of the lesion. Original scale 1:100. Credit:CC BY-SA 3.0Marvin 101/Wikiped

Updated on:April 01,2024

Multi-omics analysis identifies molecularly defined Alzheimer's disease subtypes

by Jacqueline Mitchell,Beth Israel Deaconess Medical CenterStudy design. Credit:PLOS Biology(2024). DOI: 10.1371/journal.pbio.3002607Omics analysis is the process of analyzing large

Updated on: June 15,2024

Multi-omics analysis identifies molecularly defined Alzheimer's disease subtypes

by Jacqueline Mitchell,Beth Israel Deaconess Medical CenterStudy design. Credit:PLOS Biology(2024). DOI: 10.1371/journal.pbio.3002607Omics analysis is the process of analyzing large

Updated on:June 15,2024

Experimental therapy eases Alzheimer's signs, symptoms in mice

by Carole Tanzer MillerA new cellular therapy improved learning and memory in mice with Alzheimer's disease, researchers report.The therapy—developed at the University of Nebraska Medical Center (

Updated on: February 24,2024

Experimental therapy eases Alzheimer's signs, symptoms in mice

by Carole Tanzer MillerA new cellular therapy improved learning and memory in mice with Alzheimer's disease, researchers report.The therapy—developed at the University of Nebraska Medical Center (

Updated on:February 24,2024

Consistently exercising 2–3 times a week over the long term linked to lower current insomnia risk

byBritish Medical JournalCredit: Unsplash/CC0 Public DomainConsistently exercising 2–3 times a week over the long term is linked to a lower current risk of insomnia as well as the ability to clo

Updated on: March 27,2024

Consistently exercising 2–3 times a week over the long term linked to lower current insomnia risk

byBritish Medical JournalCredit: Unsplash/CC0 Public DomainConsistently exercising 2–3 times a week over the long term is linked to a lower current risk of insomnia as well as the ability to clo

Updated on:March 27,2024

Helping children and young people isolated by young onset dementia find a voice

by University of SheffieldA pioneering study led by researchers from the University of Sheffield is helping to give a voice to children and young adults who are living with a parent with dementia

Updated on: April 29,2024

Helping children and young people isolated by young onset dementia find a voice

by University of SheffieldA pioneering study led by researchers from the University of Sheffield is helping to give a voice to children and young adults who are living with a parent with dementia

Updated on:April 29,2024

Bio-inspired neuroprosthetics: Sending signals the brain can understand

by Ori Schipper,ETH ZurichNeuroscience-driven development of a biomimetic neuroprosthetic device. The successful development of a somatosensory neuroprosthesis is based on three main pillars: (1

Updated on: April 09,2024

Bio-inspired neuroprosthetics: Sending signals the brain can understand

by Ori Schipper,ETH ZurichNeuroscience-driven development of a biomimetic neuroprosthetic device. The successful development of a somatosensory neuroprosthesis is based on three main pillars: (1

Updated on:April 09,2024

Patients with Alzheimer's disease, dementia face twice the risk of dying after ICU discharge

by American Association of Critical-Care Nurses (AACN)Outcomes after a stay in the intensive care unit for patients in cohorts with versus without Alzheimer disease and related dementia (ADRD). Credit

Updated on: April 02,2024

Patients with Alzheimer's disease, dementia face twice the risk of dying after ICU discharge

by American Association of Critical-Care Nurses (AACN)Outcomes after a stay in the intensive care unit for patients in cohorts with versus without Alzheimer disease and related dementia (ADRD). Credit

Updated on:April 02,2024

Serotonin vs. Dopamine - 7 Key Differences Between Pleasure and Happiness

Updated on: July 25,2024

Serotonin vs. Dopamine - 7 Key Differences Between Pleasure and Happiness

Updated on:July 25,2024

Improving blood vessel health in the brain may help combat Alzheimer's

by Massachusetts General HospitalPET scan of a human brain with Alzheimer's disease. Credit: public domainIn patients with Alzheimer's disease, amyloid-beta protein fragments accumulate i

Updated on: June 04,2024

Improving blood vessel health in the brain may help combat Alzheimer's

by Massachusetts General HospitalPET scan of a human brain with Alzheimer's disease. Credit: public domainIn patients with Alzheimer's disease, amyloid-beta protein fragments accumulate i

Updated on:June 04,2024

Photostimulation of lymphatic clearance of β-amyloid: A new strategy for Alzheimer's disease therapy

by Higher Education PressPhotostimulation-induced stimulation of lymphatic clearance of Aβ from the brain in 5xFAD mice. Credit: Dongyu Li, Hao Lin, Silin Sun, Shaojun Liu, Zhang Liu, Yuening He, Jing

Updated on: February 24,2024

Photostimulation of lymphatic clearance of β-amyloid: A new strategy for Alzheimer's disease therapy

by Higher Education PressPhotostimulation-induced stimulation of lymphatic clearance of Aβ from the brain in 5xFAD mice. Credit: Dongyu Li, Hao Lin, Silin Sun, Shaojun Liu, Zhang Liu, Yuening He, Jing

Updated on:February 24,2024

New memory drug moves into Phase 1 clinical study

by National Institutes of HealthAn experimental drug that may improve memory is now being tested in a Phase 1 safety trial. The compound, BPN14770, was developed by Tetra Discovery Partners, with

Updated on: February 27,2024

New memory drug moves into Phase 1 clinical study

by National Institutes of HealthAn experimental drug that may improve memory is now being tested in a Phase 1 safety trial. The compound, BPN14770, was developed by Tetra Discovery Partners, with

Updated on:February 27,2024